Tag:

RiVax

Latest Headlines

Latest Headlines

Soligenix, Infectious Disease Research Institute partner to combat anthrax

July 2, 2012 | By
Soligenix, a Princeton, NJ-based biopharmaceutical company, will partner with the Infectious Disease Research Institute of Seattle, to develop biodefense vaccines.
Related Tags
Press Releases
  • Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative
  • 23andMe Announces Collaboration with Pfizer Inc. to Conduct Genetic Research Through 23andMe's Research Platform
  • Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.
  • Enanta Announces European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Genotypes 1 and 4 Chronic Hepatitis C Virus
  • Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative
  • More Press Releases
Sponsored Links